{"id":180,"date":"2019-10-17T22:19:06","date_gmt":"2019-10-17T22:19:06","guid":{"rendered":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/chapter\/4-11-beta-1-agonist\/"},"modified":"2021-12-07T11:10:40","modified_gmt":"2021-12-07T11:10:40","slug":"4-11-beta-1-agonist","status":"publish","type":"chapter","link":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/chapter\/4-11-beta-1-agonist\/","title":{"raw":"4.11 Beta-1 Agonists","rendered":"4.11 Beta-1 Agonists"},"content":{"raw":"Dobutamine is a Beta-1 agonist.\n\nMechanism of Action:<\/strong>\u00a0 Dobutamine stimulates Beta-1 receptors to increase heart rate, force of contraction, and conduction velocity.\n\nIndications:<\/strong> Dobutamine is used to treat cardiogenic shock and severe heart failure to increase contractility and cardiac output.\n\nNursing Considerations:<\/strong> In IV administration, dilute concentration before administering. Continuously monitor electrocardiogram (ECG), blood pressure, cardiac output, and urine output during therapy. This drug can cause a marked increase in heart rate and blood pressure. Report all adverse reactions promptly, especially labored breathing, angina, palpitations, and dizziness.\n\nPatient Teaching & Education: <\/strong>The patient should be instructed to inform the nurse immediately if they notice chest pain, shortness of breath, or numbness or tingling in the extremities.[footnote]uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\n\nNow let's take a closer look at the dobutamine medication grid in Table 4.11.[footnote]This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>.[\/footnote]<\/sup>\n\nTable 4.11 Dobutamine Medication Grid\n\n\n\n\n
\n
Class\/Subclass<\/strong><\/h5>\n<\/th>\n
\n
Prototype\/Generic<\/strong><\/h5>\n<\/th>\n
\n
Administration Considerations<\/strong><\/h5>\n<\/th>\n
\n
Therapeutic Effects<\/strong><\/h5>\n<\/th>\n
\n
Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n
Beta-1 agonist<\/th>\ndobutamine<\/strong><\/a><\/td>\nContinuously monitor ECG, blood pressure, cardiac output, and urine output during therapy<\/td>\nIncreases heart rate, force of heart contraction, and speed of conduction between SA to AV nodes<\/td>\nMarked increase in heart rate and blood pressure\n\nReport all adverse reactions promptly, especially labored breathing, angina, palpitations, and dizziness<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n ","rendered":"

Dobutamine is a Beta-1 agonist.<\/p>\n

Mechanism of Action:<\/strong>\u00a0 Dobutamine stimulates Beta-1 receptors to increase heart rate, force of contraction, and conduction velocity.<\/p>\n

Indications:<\/strong> Dobutamine is used to treat cardiogenic shock and severe heart failure to increase contractility and cardiac output.<\/p>\n

Nursing Considerations:<\/strong> In IV administration, dilute concentration before administering. Continuously monitor electrocardiogram (ECG), blood pressure, cardiac output, and urine output during therapy. This drug can cause a marked increase in heart rate and blood pressure. Report all adverse reactions promptly, especially labored breathing, angina, palpitations, and dizziness.<\/p>\n

Patient Teaching & Education: <\/strong>The patient should be instructed to inform the nurse immediately if they notice chest pain, shortness of breath, or numbness or tingling in the extremities.[1]<\/sup><\/a><\/sup><\/p>\n

Now let’s take a closer look at the dobutamine medication grid in Table 4.11.[2]<\/sup><\/a><\/sup><\/p>\n

Table 4.11 Dobutamine Medication Grid<\/p>\n\n\n\n\n
\n
Class\/Subclass<\/strong><\/h5>\n<\/th>\n
\n
Prototype\/Generic<\/strong><\/h5>\n<\/th>\n
\n
Administration Considerations<\/strong><\/h5>\n<\/th>\n
\n
Therapeutic Effects<\/strong><\/h5>\n<\/th>\n
\n
Side\/Adverse Effects<\/strong><\/h5>\n<\/th>\n<\/tr>\n
Beta-1 agonist<\/th>\ndobutamine<\/strong><\/a><\/td>\nContinuously monitor ECG, blood pressure, cardiac output, and urine output during therapy<\/td>\nIncreases heart rate, force of heart contraction, and speed of conduction between SA to AV nodes<\/td>\nMarked increase in heart rate and blood pressure<\/p>\n

Report all adverse reactions promptly, especially labored breathing, angina, palpitations, and dizziness<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

  1. uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral<\/a> ↵<\/a><\/li>
  2. This work is a derivative of Daily Med<\/a> by U.S. National Library of Medicine<\/a> in the public domain<\/a>. ↵<\/a><\/li><\/ol><\/div>","protected":false},"author":2,"menu_order":11,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":"cc-by"},"chapter-type":[49],"contributor":[],"license":[53],"class_list":["post-180","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","license-cc-by"],"part":149,"_links":{"self":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":1,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/180\/revisions"}],"predecessor-version":[{"id":181,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/180\/revisions\/181"}],"part":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/149"}],"metadata":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/180\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=180"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=180"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=180"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.publishdot.com\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}